End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 CNY | -0.64% | -3.72% | -7.73% |
05-15 | China Grants Drug Registration for Huiyu Pharma's Two Injectables | MT |
04-26 | Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2022 | 1.49B 207M 282M | Sales 2023 | 927M 128M 175M | Capitalization | 6.41B 887M 1.21B |
---|---|---|---|---|---|
Net income 2022 | 249M 34.46M 47M | Net income 2023 | 140M 19.38M 26.42M | EV / Sales 2022 | 2.73 x |
Net cash position 2022 | 2.53B 350M 477M | Net cash position 2023 | 2.14B 296M 404M | EV / Sales 2023 | 4.6 x |
P/E ratio 2022 |
26.4
x | P/E ratio 2023 |
45.8
x | Employees | 1,669 |
Yield 2022 |
1.51% | Yield 2023 |
1.41% | Free-Float | 39.27% |
1 day | -0.64% | ||
1 week | -3.72% | ||
Current month | -2.72% | ||
1 month | +15.75% | ||
3 months | +17.41% | ||
6 months | -7.00% | ||
Current year | -7.73% |
Managers | Title | Age | Since |
---|---|---|---|
Zhao Ding
CEO | Chief Executive Officer | 39 | 10-10-11 |
Lan Gao
DFI | Director of Finance/CFO | 53 | 19-10-13 |
Li Na Ma
BRD | Director/Board Member | 48 | 22-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Li Na Ma
BRD | Director/Board Member | 48 | 22-04-30 |
Lan Gao
DFI | Director of Finance/CFO | 53 | 19-10-13 |
Zhao Ding
CEO | Chief Executive Officer | 39 | 10-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 13.96 | -0.64% | 917,145 |
24-05-15 | 14.05 | -1.40% | 1,337,019 |
24-05-14 | 14.25 | -2.26% | 1,721,199 |
24-05-13 | 14.58 | +1.39% | 2,893,587 |
24-05-10 | 14.38 | -0.83% | 1,921,866 |
End-of-day quote Shanghai S.E., May 15, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-7.73% | 819M | |
+32.36% | 694B | |
+30.17% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.43% | 239B | |
+10.38% | 209B | |
-3.07% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 688553 Stock